Your browser doesn't support javascript.
loading
A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetes.
Yang, S J; Min, K W; Gupta, S K; Park, J Y; Shivane, V K; Pitale, S U; Agarwal, P K; Sosale, A; Gandhi, P; Dharmalingam, M; Mohan, V; Mahesh, U; Kim, D M; Kim, Y S; Kim, J A; Kim, P K; Baik, S H.
Affiliation
  • Yang SJ; Division of Endocrinology, Department of Internal Medicine, Korea University, Guro Hospital, Seoul, Korea.
Diabetes Obes Metab ; 15(5): 410-6, 2013 May.
Article in En | MEDLINE | ID: mdl-23170990
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidones / Pyrimidines / Blood Glucose / Exercise / Diabetes Mellitus, Type 2 / Diet / Dipeptidyl-Peptidase IV Inhibitors Type of study: Clinical_trials / Etiology_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2013 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidones / Pyrimidines / Blood Glucose / Exercise / Diabetes Mellitus, Type 2 / Diet / Dipeptidyl-Peptidase IV Inhibitors Type of study: Clinical_trials / Etiology_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2013 Document type: Article